Follow The Filings

EQ Equillium

Equillium earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.04 —
Rev — — —

Insider trades

Open-market buys and sales by EQ's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EQ insider trades
  • None no insider bought on the open market
  • $724K sold by 1 insider outside a trading plan
  • $1.7M sold by 2 insiders under 10b5-1 plans
  1. Christine Zedelmayer COO
    Planned sale
    $43K 14,584 shares at $2.93 19% of stake
    Traded Jun 5 Filed Jun 5
  2. Stephen Connelly President and CSO
    Sale
    $724K 230,975 shares at $3.13 23% of stake
    Traded Jun 4–5 Filed Jun 5
  3. Penny Tom Principal Accounting Officer
    Planned sale
    $192K 65,000 shares at $2.95 100% of stake
    Traded May 28 Filed May 29
  4. Christine Zedelmayer COO
    Planned sale
    $267K 95,833 shares at $2.79 61% of stake
    Traded May 27–28 Filed May 29
  5. Christine Zedelmayer COO
    Planned sale
    $301K 120,312 shares at $2.50 66% of stake
    Traded Mar 13 Filed Mar 16
  6. Christine Zedelmayer COO
    Planned sale
    $328K 185,937 shares at $1.76 67% of stake
    Traded Feb 19 Filed Mar 11
  7. Christine Zedelmayer COO
    Planned sale
    $362K 181,219 shares at $2.00 74% of stake
    Traded Mar 9 Filed Mar 11
  8. Penny Tom Principal Accounting Officer
    Planned sale
    $8,428 6,533 shares at $1.29 100% of stake
    Traded Jan 8 Filed Jan 9
  9. Christine Zedelmayer COO
    Planned sale
    $150K 100,000 shares at $1.50 52% of stake
    Traded Dec 23, 2025 Filed Dec 23, 2025
  10. Christine Zedelmayer COO
    Planned sale
    $47K 35,704 shares at $1.33 28% of stake
    Traded Dec 12–15 Filed Dec 15, 2025
  11. Christine Zedelmayer COO
    Planned sale
    $7,696 8,098 shares at $0.9500 6% of stake
    Traded Nov 25, 2025 Filed Nov 25, 2025

Also filed in the last 12 months, not counted as buying or selling: 14 option exercises.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 8.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.07,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A
8-K 2.02,9.01
10-K
SCHEDULE 13G —
8-K 1.01,3.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.